Back to LCT Homepage Targeting Huntington's Disease, Stroke, Type 1 Diabetes and Haemophilia
Information about LCT Living Cell Technologies
LCT - Living Cell Technologies
News updates: Subscribe
Unsubscribe


June 5, 2008
LCT Expands Diabetes Clinical Trial
June 3, 2008
LCT Lists on International OTCQX
May 21, 2008
LCT interviewed by New Zealand TV program, Close Up
May 12, 2008
LCT presents encapsulation technology at conference
May 8, 2008
LCT features on Channel Ten News
May 8, 2008
LCT prepares to list on international OTCQX
 

Media

November 2004

Long-term safety of transplanted pig cells to humans confirmed more
November 4, 2004

Confirmation details of Share Placement more
November 3, 2004

 

October 2004

Change of address more
October 29, 2004

LCT completes treatment phase of their pre-clinical study to treat diabetes more
October 27, 2004

LCT treatment protects the brain from damage by Huntington’s disease more
October 22, 2004

 

September 2004

LCT diabetes treatment successful in pre-clinical trials more
September 7, 2004

LCT report successful liver cell implantation more
September 7, 2004

LCT lists on the ASX more
September 1, 2004

 

August 2004

LCT closes successful IPO more
August 26, 2004

 

June 2004

Human diabetes trial in Italy lends strong support for LCT technology more
June 7, 2004

 

May 2004

Potential new treatment for stroke and neurodegenerative disease published in Neuro Report more
May 6, 2004

 

April 2004

Living Cell Technologies attracts international business leader as Chairman more
April 7, 2004

Archive 2007

Archive 2006

Archive 2005

LCT - Living Cell Technologies
What is xenotransplantation?
The use of living animal cells, tissues or organs in human therapeutics. >more

What is DiabeCell?
DiabeCell is a porcine pancreatic cell product for the treatment of insulin-dependent diabetes. >more

What is NeurotrophinCell?
A choroid plexus (brain) cell product with the potential to treat diseases of the nervous system such as Huntington's disease and stroke. >more

What is LCT's encapsulation technology?
The living cells are covered in a seaweed-derived coating (alginate encapsulation) to form capsules which eliminate the
need for toxic immunosuppressant drugs and allow the release of beneficial factors.
>more
   
graphic design and website design - PDF Communications Ltd